Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Mayne Pharma Group ( (AU:MYX) ).
Mayne Pharma Group has announced that Mitsubishi UFJ Financial Group, through its subsidiary First Sentier Investors Holdings Pty Limited, has acquired a substantial holding in the company. This acquisition grants Mitsubishi UFJ Financial Group significant voting power and influence over Mayne Pharma’s operations, potentially impacting its strategic direction and market positioning.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$6.69 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 976,422
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$364M
See more insights into MYX stock on TipRanks’ Stock Analysis page.